학술논문
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12
Document Type
Artikel
Author
Source
Gynecologic oncology. 152(2):235-242
Subject
Language
English
English
English
ISSN
1095-6859